Mefloquine labels and packages

Revision as of 04:35, 8 January 2014 by Chetan Lokhande (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Mefloquine
MEFLOQUINE HYDROCHLORIDE® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Labels And Packages

TEVA PHARMACEUTICALS USA

Sellersville, PA 18960

Rev. B 6/2013

PRINCIPAL DISPLAY PANEL[1]

[[File:|800px|thumb]]


Mefloquine HCl Tablets USP 250mg 25s Carton Text

NDC 0555-0171-78

MEFLOQUINE HCl Tablets USP 250 mg

Each tablet contains 250 mg mefloquine hydrochloride USP.

PHARMACIST: Dispense the enclosed Medication Guide to each patient.

Rx only

25 UNIT-DOSE TABLETS (5 x 5)

TEVA


References

  1. "MEFLOQUINE HYDROCHLORIDE TABLET [BARR LABORATORIES INC.]".

Adapted from the FDA Package Insert.